Union Piroxicam Injection

Adult dosage

(Oral) Adults: Administer piroxicam 20 mg orally once daily. The maximum recommended daily dose is 20 mg of piroxicam. To reduce the risk of adverse reactions, use the lowest effective dose for the shortest duration. The therapeutic effect and tolerability should be reviewed within 14 days of starting this drug. If continued treatment is considered necessary, more frequent reviews should be conducted. (Injection) Adults: Administer piroxicam 20 mg by intramuscular injection once daily. The maximum recommended daily dose is 20 mg of piroxicam. To reduce the risk of adverse reactions, use the lowest effective dose for the shortest duration. The therapeutic effect and tolerability should be reviewed within 14 days of starting this drug. If continued treatment is considered necessary, more frequent reviews should be conducted. The oral or suppository formulation of this drug may be administered concomitantly, but the total daily dose via both routes must not exceed the maximum recommended daily dose.

This medication may increase the risk of gastrointestinal bleeding in individuals who regularly consume more than three alcoholic beverages daily; therefore, medical consultation with a doctor or pharmacist is mandatory. Patients with cardiovascular diseases or risk factors should be monitored closely for cardiovascular problems such as myocardial infarction or stroke while taking this medication. This medication can cause serious gastrointestinal issues such as bleeding, ulcers, and perforation, so patients with a history of gastrointestinal diseases should not use it. Symptoms should be monitored carefully during treatment. Elderly patients and those with a history of gastrointestinal disease are at greater risk of side effects and require special attention when taking this medication. Severe allergic reactions on the skin, rashes, desquamative dermatitis, etc., may occur, so use should be discontinued immediately if any skin abnormalities arise. Products containing benzyl alcohol can cause life-threatening respiratory issues in premature infants; thus, they should not be used in newborns or premature infants. Patients with a history of gastrointestinal ulcers, bleeding, perforation, severe liver or kidney impairment, heart failure, hypertension, pregnant women, breastfeeding women, children, and the elderly (over 80 years old) should avoid this medication. Patients with a history of peptic ulcers, blood disorders, liver or kidney impairment, heart failure, hypertension, asthma, etc., should use this medication cautiously and only under a doctor's guidance. This medication can cause various side effects, such as dyspepsia, nausea, vomiting, diarrhea, skin rashes, blood disorders, kidney function decline, and neurological symptoms, so any unusual symptoms should be reported to healthcare providers immediately. Long-term use may require regular blood tests and liver/kidney function monitoring to check for abnormalities, with adjustments in dosage or discontinuation possible as needed. This medication should not be used concurrently with other non-steroidal anti-inflammatory drugs, and interactions with certain medications may increase the risk of side effects, so it is crucial to inform the doctor of all medications being taken. During late pregnancy, this medication may pose risks to the fetus; therefore, pregnant women should not use it, and breastfeeding women should also refrain from using it for safety. Children and elderly individuals over 80 years old should avoid this medication as its safety and efficacy have not been established in these populations. In the case of overdose, symptoms may include drowsiness, nausea, vomiting, gastrointestinal bleeding, etc., requiring immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers to maintain its quality.

Gastrointestinal bleeding, peptic ulcer, hematemesis, melena, epigastric pain, discomfort in the upper abdomen, loss of appetite, nausea, vomiting, diarrhea, loose stools, stomatitis, indigestion, abdominal bloating, constipation, glossitis, shock, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Stevens-Johnson syndrome, Lyell syndrome, photosensitivity reaction, onycholysis, abnormal nail growth, hair loss, vesiculobullous reaction, anemia, granulocytopenia, thrombocytopenia, aplastic anemia, bone marrow suppression, purpura, leukopenia, pancytopenia, eosinophilia, hypertension, congestive heart failure, acute cardiac conditions, jaundice, hepatitis, elevated AST/ALT, elevated ALP, elevated LDH, acute renal failure, fluid retention, oliguria, hematuria, proteinuria, elevated BUN, elevated serum creatinine, hyperkalemia, rash, pruritus, bronchospasm, urticaria, angioedema, vasculitis, serum sickness, drowsiness, dizziness, headache, tinnitus, numbness of hands and feet, depression, irritability, hallucinations, emotional instability, mental confusion, allergic edema of the face and hands, dry mouth, generalized malaise, blurred vision, eye irritation, shoulder stiffness, fever, palpitations, dyspnea

This medication should be stored in a sealed container that can block light. The storage temperature should be maintained between 1 and 30 degrees Celsius to preserve the drug's effectiveness over time.

Appearance

A brown ampoule containing a light yellow liquid

Package unit

1ml × 50 ampoules